Policy Papers The EveryLife Foundation Submits Comments on the Impacts of PFDD Meetings July 01, 2026 Share this page The EveryLife Foundation for Rare Diseases submitted comments in response to the FDA’s request for information on the impacts of Patient-Focused Drug Development (PFDD) meetings Patient-Focused Drug Development (PFDD) Related Articles Breaking News: The FDA has released the draft goals letter for PDUFA VIII August 13, 2026 The EveryLife Foundation Submits Comments to Support Patient-Focused Drug Development and Medical Innovation July 01, 2026 The EveryLife Foundation Submits Comments in Response to Rep. Auchincloss' Request July 01, 2026 See All News